Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02869451 · ClinicalTrials.gov registry record · NA
Mobile Contingency Management for Marijuana and Tobacco Cessation
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02869451: Completed NA study, sponsored by Duke University.
NCT02869451 is a NA study that has completed, run by Duke University. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02869451, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this pilot project is to pilot-test a combined cannabis and smoking cessation treatment. The intervention combines mobile technology with behavioral strategies, counseling, and medications.
Primary Outcome
Participants self-report smoking behavior since smoking quit date. Prolonged abstinence is defined as sustained abstinence since two weeks post-initial smoking quit date.
Interventions
- DRUG bupropion
- DRUG Nicotine polacrilex
- DRUG transdermal nicotine patch
- DRUG nicotine lozenge
- BEHAVIORAL counseling for marijuana and smoking cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-05-17 |
| Phase | NA |
What the finished NCT02869451 record still lists
NCT02869451 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 5 interventions - of which bupropion is the first listed.
NCT02869451 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02869451 about?
NCT02869451 is a clinical study titled "Mobile Contingency Management for Marijuana and Tobacco Cessation". The purpose of this pilot project is to pilot-test a combined cannabis and smoking cessation treatment. The intervention combines mobile technology with behavioral strategies, counseling, and medications.
What is the current status of trial NCT02869451?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2016-08. Estimated completion is 2017-05-17.
What interventions are being tested in trial NCT02869451?
The interventions under investigation include: bupropion (DRUG), Nicotine polacrilex (DRUG), transdermal nicotine patch (DRUG), nicotine lozenge (DRUG), counseling for marijuana and smoking cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT02869451?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02869451's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia